Eliminating Hepatitis C in Spain
<p id="p1">In Spain, the global hepatitis C epidemic has been addressed through a comprehensive national strategy implemented within the publicly funded universal healthcare system. This ambitious initiative includes an epidemiological study conducted in 2017–2018 that reported a 0.85% prevale...
Guardado en:
| Autores principales: | , |
|---|---|
| Formato: | Capítulo de libro |
| Lenguaje: | inglés |
| Publicado: |
IntechOpen
2025
|
| Materias: | |
| Acceso en línea: | https://www.intechopen.com/chapters/89832 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| Sumario: | <p id="p1">In Spain, the global hepatitis C epidemic has been addressed through a comprehensive national strategy implemented within the publicly funded universal healthcare system. This ambitious initiative includes an epidemiological study conducted in 2017–2018 that reported a 0.85% prevalence of HCV antibodies and 0.22% prevalence of active infection in the population. The highest active infection rates were found in men aged 50–59 years (0.86%) and 60–69 years (0.72%). Notably, 29.4% of HCV infections were undiagnosed. The plan established the criteria for receiving HCV therapy: all patients with positive HCV RNA testing and no contraindications would be treated, and all pangenotypic regimens (e.g., sofosbuvir/velpatasvir and glecaprevir/pibrentasvir) would be reimbursed. The Ministry of Health, regional governments, and various sectors in Spain have set up HCV elimination plans and other measures to control spread of the infection and mitigate its impact on the population. This chapter discusses strategic Plan for Addressing Hepatitis C in Spain in the National Health System), including micro-elimination schemes and strategies for linking patients to care.</p> |
|---|---|
| ISBN: | 978-1-80632-102-5 |
| DOI: | 10.5772/intechopen.115655 |